1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 5:Findings of unenhanced and contrast-enhanced 3D TOF MRA compared with DSA
MRA Finding DSA Finding Residual Neck Complete Occlusion Unenhanced MRA Residual neck 24 4 Complete occlusion 3 46 Percentage 88.9 (70.1–97.6) 92 (80.8–97.7) Contrast-enhanced MRA Residual neck 30 5 Complete occlusion 4 72 Percentage 88.2 (72.6–96.7) 93.5 (85.5–97.7)
Note:—TOF indicates time of flight; MRA, magnetic resonance angiography; DSA, digital subtraction angiography. Percentages represent sensitivity (left column) and specificity (right column); figures in parentheses are 95% confidence intervals.